Intrinsiqs

Is Ginkgo Bioworks Holdings, Inc. overvalued?

Ginkgo Bioworks Holdings, Inc. (DNA) — key valuation metrics and fundamentals.

No verdict
Price
$6.79
Fair value
Current P/E
Normal P/E
Market cap
$443.6M
Dividend yield
0.0%
Return on equity
-60.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares DNA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.